Michael R. McMullen

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Bristol Myers Squibb Co publishes a filing, an earnings call transcript or a press release.

Get BMY alerts

About Michael R. McMullen

Michael R. McMullen is recorded as Board Member at Bristol Myers Squibb Co (BMY) since July 1, 2024. Bristol Myers Squibb Co reported in an 8-K filed June 18, 2024 that Michael R. McMullen was appointed member of the Board, effective July 1, 2024. Bristol Myers Squibb Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Bristol Myers Squibb Co includes Christopher Boerner (CEO, COO and Board Member), Christopher Boerner, Ph.D. (CEO, COO and Board Member), David Elkins (CFO) and 5 others.

“On June 18, 2024, the Board of Directors (the "Board") of Bristol-Myers Squibb Company (the "Company") elected Mr. Michael R. McMullen to serve as a member of the Board, effective July 1, 2024.”

Bristol Myers Squibb Co Form 8-K, filed June 18, 2024 · Read the filing

Affiliation history

Bristol Myers Squibb Co (BMY)
Board Member

SEC 8-K

Current
2024-07-01–present

Company network

Bristol Myers Squibb Co

BMY

Current role

Drug Manufacturers - General · Healthcare

Board Member

2024-07-01–present

Leadership on record at Bristol Myers Squibb Co

Christopher Boerner CEO, COO, Board Member
Christopher Boerner, Ph.D. CEO, COO, Board Member
David Elkins CFO
Sandra Leung General Counsel
Deepak L. Bhatt, M.D., M.P.H. Board Member
Derica W. Rice Board Member
Manuel Hidalgo Medina Board Member
Paula A. Price Board Member

Recent activity

Executive change Appointed: member of the Board Bristol Myers Squibb Co (BMY)
2024-07-01